23 Sept 2024
17m
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management
Clinical Journal of the American Society of Nephrology (CJASN)
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.